Frank Torti’s Next 100 Days: Active, Not Just Acting, FDA Commissioner
This article was originally published in The Rose Sheet
Executive Summary
Frank Torti might not be in charge of FDA for very long, but he seems determined to make his time count
You may also be interested in...
Von Eschenbach Resigning In January With BTC Debate In His Legacy
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, leaving a legacy that includes restarting discussions on whether a third class of drugs is needed
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle